文献速递瓣膜外科

接受孤立性三尖瓣修复或置换手术患者的结局

Outcome of patients undergoing isolated tricuspid repair or replacement surgery.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

Surgical-Tricuspid 研究为多中心回顾性研究,纳入 13 个国际中心 426 例接受孤立性三尖瓣手术的成人患者,经倾向性评分匹配后分析 175 对可比病例。结果显示置换组早期再探查、起搏器植入和输血率更高,修复组 3、5、7 年累积生存率更高,两组 10 年再手术累积发生率无差异。

要点

  • 孤立性三尖瓣手术患者风险较高,30 天死亡率修复组 4.0% vs 置换组 8.0%(P=0.115)。
  • 置换组永久起搏器植入率 12.0% 高于修复组 5.1%(P=0.022)。
  • 修复组 3、5、7 年累积生存率均高于置换组(P=0.001),10 年再手术率无差异。

核心结论

  • 孤立性三尖瓣修复与置换相比,早期和晚期死亡率更低,再手术率无差异。

研究设计与样本

  • Surgical-Tricuspid 研究为多中心回顾性研究,纳入 13 个国际中心接受孤立性三尖瓣手术的成人患者 426 例,采用倾向性评分匹配比较修复与置换。

主要发现

  • 匹配后分析 175 对可比病例,术前左心室射血分数修复组 55(9)% vs 置换组 56(9)%(P=0.8),95% 病例存在中重度三尖瓣反流。
  • 30 天死亡率修复组 4.0% vs 置换组 8.0%(P=0.115)。
  • 因出血再探查率修复组 6.9% vs 置换组 13.1%(P=0.050),永久起搏器植入率修复组 5.1% vs 置换组 12.0%(P=0.022),输血率修复组 46% vs 置换组 62%(P=0.002)。
  • 3、5、7 年累积生存率修复组分别为 84(3)%、75(4)%、56(9)%,置换组分别为 71(4)%、66(5)%、58(5)%(P=0.001)。
  • 10 年再手术累积发生率修复组 10(1)% vs 置换组 9(1)%(P=0.469)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The interest in isolated tricuspid valve disease has rapidly increased recently. However, clinical trials and registry data are rare in the surgical literature. This study aimed to describe the early and long-term outcomes of a real-world experience in isolated tricuspid procedures comparing repair and replacement strategies. METHODS: The Surgical-Tricuspid study is a multicentre retrospective study that enrolled adult patients who had undergone isolated tricuspid valve surgery at 13 international sites. Propensity score-matched analysis was used to compare repair versus replacement. RESULTS: A cohort of 426 patients was enrolled [mean age: 55 (16) years; 56% female]. After matching, 175 comparable pairs were analysed. Preoperative left ventricular ejection fraction was 55(9) vs 56(9) (P = 0.8) while moderate-severe tricuspid regurgitation was present in 95% of cases. The 30-day mortality rate was 4.0% vs 8.0% in the repair and replacement groups, respectively (P = 0.115). The rates of re-exploration for bleeding (6.9% vs 13.1% P = 0.050), permanent pacemaker implantation (5.1% vs 12.0%; P = 0.022) and blood transfusion (46% vs 62%; P = 0.002) were higher in the replacement group. Cumulative survival rates at 3, 5 and 7 years in the repair group were 84 (3)%, 75 (4)% and 56 (9)% vs 71 (4)%, 66 (5)% and 58 (5)% in the replacement group (P = 0.001) while cumulative incidence for reoperation at 10 years did not differ between groups [repair 10 (1)% vs replacement 9 (1)%; P = 0.469]. CONCLUSIONS: The data from the Surgical-Tricuspid study reported a high risk for patients undergoing tricuspid surgery. Isolated valve repair offered reduced early and late mortality with no difference regarding reoperation rate when compared with replacement.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Russo M, Di Mauro M, Saitto G, et al. Outcome of patients undergoing isolated tricuspid repair or replacement surgery. Eur J Cardiothorac Surg. 2022. PMID: 35448903. doi:10.1093/ejcts/ezac230

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。